IP Library Granted Patent US 8,859,770
Granted Patent B2
US 8,859,770 · App. 14/116,876 · Granted Oct 14, 2014

Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,770
App. No.
14/116,876
Granted
Oct 14, 2014
Kind
B2
Abstract

The present invention relates to a process for preparing a compound of formula (I).

Claims (24)

1. A process for preparing a compound of formula (I)

the process comprising reacting a compound of formula (III)

with 4-trifluoromethylbenzoyl chloride in the presence of a second base and methanol to obtain a compound of formula (II)

and then hydrolyzing the compounds of formula (II) in the presence of a first base and of a solvent or of a mixture of solvents to obtain the compound of formula (I).

2. The process according to claim 1 , wherein the first base is the monohydrate of LiOH.

3. The process according to claim 1 , wherein the solvent or the mixture of solvents is a mixture of tetrahydrofuran, methanol, and water.

4. The process according to claim 1 , wherein the obtained reaction mixture comprising a salt of the compound of formula (I) is subsequently neutralized with acetic acid.

5. The process according to claim 1 , wherein the second base is diisopropylethylamine.

6. The process according to claim 1 , wherein the compound of formula (III) is obtained by hydrogenation of a compound of formula (IV)

7. The process according to claim 6 , wherein the hydrogenation takes place in the presence of palladium on activated charcoal.

8. The process according to claim 6 , wherein the compound of formula (III) is isolated from isopropanol as its free base.

9. The process according to claim 6 , wherein the compound of formula (IV) is obtained by reacting a compound of formula (V)

with an excess of dimethylamine in the presence of a solvent or of a mixture of solvents.

10. The process according to claim 9 , wherein the solvent or the mixture of solvents is isopropyl acetate.

11. The process according to claim 9 , wherein the hydrogenation of the compound of formula (IV) is subsequently performed without prior isolation.

12. The process according to claim 11 , wherein the reaction mixture is washed with water prior to performing the hydrogenation.

13. The process according to claim 9 , wherein the compound of formula (V) is obtained by reacting a compound of formula (VI)

with a chlorinating agent in the presence of a third base.

14. The process according to claim 13 , wherein the chlorinating agent is POCl 3 .

15. The process according to claim 13 , wherein the third base is triethylamine.

16. The process according to claim 9 , wherein the compound of formula (VI) is obtained by reacting a compound of formula (VII) or a hydrohalogenide thereof

with trimethyl 1,1,2-ethantricarboxylate in the presence of a fourth base.

17. The process according to claim 16 wherein the fourth base is sodium methylate.

18. The process according to claim 16 , wherein the compound of formula (VII) or the hydrohalogenide thereof is obtained by reacting 4-nitrophenylacetonitril in the presence of methanol and acetyl chloride and subsequently reacting the obtained intermediate with ammonia.

Assignments (5)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY COLLATERAL AT REEL/FRAME NO. 49081/0335 Recorded May 3, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.; GB003, INC.; GB004, INC.; GB005, INC.; GB007, INC.; GB008, INC.
Reel/Frame 067310/0307 →
MERGER AND CHANGE OF NAME Recorded Jun 6, 2019
From: ACTIMIS PHARMACEUTICALS, INC.; GB007 MERGER SUB, INC.
To: GB007, INC.
Reel/Frame 049394/0181 →
SECURITY INTEREST Recorded May 3, 2019
From: GOSSAMER BIO, INC.; GOSSAMER BIO SERVICES, INC.; GB001, INC.; GB002, INC.; GB003, INC.; GB004, INC.; GB005, INC.; GB006, INC.; GB007, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 049081/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2017
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: ACTIMIS PHARMACEUTICALS, INC.
Reel/Frame 042149/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2014
From: RODRIGUEZ DEHLI, JUAN M.; SCHUL, MICHAEL; STANGE, CHRISTIAN; HAGENKOETTER, ROBERT; WANG, XIAO-JUN; ZHANG, LI; MASSOT, ORIOL
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 032786/0409 →